Matches in SemOpenAlex for { <https://semopenalex.org/work/W3190201601> ?p ?o ?g. }
- W3190201601 endingPage "105816" @default.
- W3190201601 startingPage "105816" @default.
- W3190201601 abstract "Experimental autoimmune encephalomyelitis (EAE) is an animal model of multiple sclerosis (MS), in which myeloid cells sustain inflammation, take part in priming, differentiation, and reactivation of myelin-specific T cells, and cause direct myelin damage. N-Acylethanolamine-hydrolyzing acid amidase (NAAA) is a proinflammatory enzyme induced by phlogosis and overexpressed in macrophages and microglia of EAE mice. Targeting these cell populations by inhibiting NAAA may be a promising pharmacological strategy to modulate the inflammatory aspect of MS and manage disease progression. To address this goal, we used ARN16186, a small molecule specifically designed and synthesized as a pharmacological tool to inhibit NAAA. We assessed whether enzyme inhibition affected the severity of neurological symptoms and modulated immune cell infiltration into the central nervous system of EAE mice. We found that preventive chronic treatment with ARN16186 was efficacious in slowing disease progression and preserving locomotor activity in EAE mice. Furthermore, NAAA inhibition reduced the number of immune cells infiltrating the spinal cord and modulated the overactivation of NF-kB and STAT3 transcription factors, leading to less expansion of Th17 cells over the course of the disease." @default.
- W3190201601 created "2021-08-16" @default.
- W3190201601 creator A5006027549 @default.
- W3190201601 creator A5014654491 @default.
- W3190201601 creator A5023227212 @default.
- W3190201601 creator A5028711202 @default.
- W3190201601 creator A5040601627 @default.
- W3190201601 creator A5055537729 @default.
- W3190201601 creator A5063116679 @default.
- W3190201601 creator A5064421052 @default.
- W3190201601 creator A5072224755 @default.
- W3190201601 creator A5080893795 @default.
- W3190201601 date "2021-10-01" @default.
- W3190201601 modified "2023-09-25" @default.
- W3190201601 title "Inhibition of N-acylethanolamine-hydrolyzing acid amidase reduces T cell infiltration in a mouse model of multiple sclerosis" @default.
- W3190201601 cites W1532153797 @default.
- W3190201601 cites W1538907359 @default.
- W3190201601 cites W1590854724 @default.
- W3190201601 cites W1607206274 @default.
- W3190201601 cites W1968917850 @default.
- W3190201601 cites W1971874355 @default.
- W3190201601 cites W1972891843 @default.
- W3190201601 cites W1973101671 @default.
- W3190201601 cites W1978333249 @default.
- W3190201601 cites W1999768705 @default.
- W3190201601 cites W2002729523 @default.
- W3190201601 cites W2007373797 @default.
- W3190201601 cites W2027027613 @default.
- W3190201601 cites W2028098820 @default.
- W3190201601 cites W2029132318 @default.
- W3190201601 cites W2032671409 @default.
- W3190201601 cites W2042233123 @default.
- W3190201601 cites W2045872436 @default.
- W3190201601 cites W2055404309 @default.
- W3190201601 cites W2072488504 @default.
- W3190201601 cites W2078621743 @default.
- W3190201601 cites W2082711927 @default.
- W3190201601 cites W2090706382 @default.
- W3190201601 cites W2095720174 @default.
- W3190201601 cites W2096618637 @default.
- W3190201601 cites W2101520046 @default.
- W3190201601 cites W2110733863 @default.
- W3190201601 cites W2111361033 @default.
- W3190201601 cites W2149287982 @default.
- W3190201601 cites W2149554987 @default.
- W3190201601 cites W2150503227 @default.
- W3190201601 cites W2157400187 @default.
- W3190201601 cites W2162981836 @default.
- W3190201601 cites W2165128851 @default.
- W3190201601 cites W2237743828 @default.
- W3190201601 cites W2254196881 @default.
- W3190201601 cites W2263348599 @default.
- W3190201601 cites W2313433907 @default.
- W3190201601 cites W2325852107 @default.
- W3190201601 cites W2408746493 @default.
- W3190201601 cites W2411336333 @default.
- W3190201601 cites W2474684543 @default.
- W3190201601 cites W2505649614 @default.
- W3190201601 cites W2557010433 @default.
- W3190201601 cites W2605033539 @default.
- W3190201601 cites W2765598003 @default.
- W3190201601 cites W2792235843 @default.
- W3190201601 cites W2794025173 @default.
- W3190201601 cites W2800776367 @default.
- W3190201601 cites W2903438978 @default.
- W3190201601 cites W2911001014 @default.
- W3190201601 cites W2925295678 @default.
- W3190201601 cites W2944741954 @default.
- W3190201601 cites W2946323135 @default.
- W3190201601 cites W2950108987 @default.
- W3190201601 cites W2981126640 @default.
- W3190201601 cites W2984486845 @default.
- W3190201601 cites W2997708552 @default.
- W3190201601 cites W3006836229 @default.
- W3190201601 cites W3040631128 @default.
- W3190201601 cites W3080773836 @default.
- W3190201601 cites W3097943335 @default.
- W3190201601 cites W3177840625 @default.
- W3190201601 cites W3198241337 @default.
- W3190201601 doi "https://doi.org/10.1016/j.phrs.2021.105816" @default.
- W3190201601 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34391933" @default.
- W3190201601 hasPublicationYear "2021" @default.
- W3190201601 type Work @default.
- W3190201601 sameAs 3190201601 @default.
- W3190201601 citedByCount "6" @default.
- W3190201601 countsByYear W31902016012021 @default.
- W3190201601 countsByYear W31902016012022 @default.
- W3190201601 countsByYear W31902016012023 @default.
- W3190201601 crossrefType "journal-article" @default.
- W3190201601 hasAuthorship W3190201601A5006027549 @default.
- W3190201601 hasAuthorship W3190201601A5014654491 @default.
- W3190201601 hasAuthorship W3190201601A5023227212 @default.
- W3190201601 hasAuthorship W3190201601A5028711202 @default.
- W3190201601 hasAuthorship W3190201601A5040601627 @default.
- W3190201601 hasAuthorship W3190201601A5055537729 @default.
- W3190201601 hasAuthorship W3190201601A5063116679 @default.
- W3190201601 hasAuthorship W3190201601A5064421052 @default.
- W3190201601 hasAuthorship W3190201601A5072224755 @default.